Correlation Between Milestone Pharmaceuticals and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Spyre Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Spyre Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Spyre Therapeutics
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Milestone and Spyre is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Spyre Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.22 times less return on investment than Spyre Therapeutics. But when comparing it to its historical volatility, Milestone Pharmaceuticals is 1.55 times less risky than Spyre Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 2,744 in Spyre Therapeutics on August 27, 2024 and sell it today you would earn a total of 26.00 from holding Spyre Therapeutics or generate 0.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Spyre Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Spyre Therapeutics |
Milestone Pharmaceuticals and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Spyre Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Spyre Therapeutics vs. Eliem Therapeutics | Spyre Therapeutics vs. HCW Biologics | Spyre Therapeutics vs. Scpharmaceuticals | Spyre Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |